![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=50)
侵略性T细胞淋巴瘤:2024年:关于诊断,风险分层和管理的最新信息
Shin Yeu Ong1,2, Jasmine M Zain1
1Department of Hematology/Hematopoietic Cell Transplantation, City of Hope Medical Center, Duarte, California, USA.
American journal of hematology
|February 2, 2024
概括
周围T细胞淋巴瘤 (PTCL) 的预后不好. 分子理解的进步正在推动针对性疗法和免疫疗法的开发,以改善PTCL治疗结果.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 周围T细胞淋巴瘤 (PTCL) 包含30多种亚型,预后不佳.
- 仅仅基因组学变异并不能完全捕捉PTCL亚型的异质性.
研究的目的:
- 审查各种PTCL亚型的分子病原性.
- 讨论PTCL治疗的新兴向疗法和免疫疗法.
主要方法:
- 对基因表达造型和分子技术的审查.
- 对针对性药物和免疫疗法的当前临床试验的分析.
主要成果:
- 分子技术揭示了PTCL亚型之间的明显差异,为世界卫生组织第五次分类提供了信息.
- 向药物 (例如,布伦图西马布维多丁,PI3K抑制剂,HDAC抑制剂,ALK抑制剂) 和免疫疗法 (例如,检查点抑制剂,CAR-T) 是有前途的.
- 异构干细胞移植仍然是积极PTCL的治疗选择.
结论:
- 了解PTCL分子病原性对于开发有效疗法至关重要.
- 向药物和新型免疫疗法对于改善PTCL的临床结果至关重要.
- 需要进一步的研究和临床试验,以优化各种PTCL亚型的治疗策略.
更多相关视频
06:08Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
Published on: February 10, 2023
1.4K
09:56A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
Published on: February 21, 2025
531
相关概念视频
01:27Tumor Immunotherapy
526
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
526
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
02:07Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
01:30Cancer Vaccines
367
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
367